Posted on 6 月 5, 20246/5/24
FDA Guidance and Considerations for Scientific Exchange Communication Strategies
Posted on 5 月 23, 20245/23/24
Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
Posted on 5 月 23, 20245/23/24
Integrated Delivery Networks (IDNs): Driving Change in Drug Access and Utilization
Posted on 5 月 12, 20245/12/24
Maximizing Sales Impact in a Hybrid World
Posted on 5 月 10, 20245/10/24
Equip FRMs with the Right Tools to Unlock Patient Access
Posted on 3 月 1, 20243/1/24
Future-Proofing Demands Proof: How Innovators Are Transforming Pharma Commercialization
Posted on 1 月 23, 20241/23/24
Redefining Field Deployment – Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
Posted on 11 月 28, 202311/28/23
There’s a New Way to Omnichannel: Orchestrating Experience to Drive Sales, Savings and Satisfaction
Posted on 9 月 7, 20239/7/23
Orchestrating Experiences That Simultaneously Drive Brand Impact and Customer Delight
Posted on 9 月 7, 20239/7/23